Mitchell H. Keylor

Merck & Co., Inc., Rahway, NJ, USA (United States)

ChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Leveraging the persistent radical effect in the synthesis of trans-2,3-diaryl-dihydrobenzofurans”.

Leveraging the persistent radical effect in the synthesis of trans-2,3-diaryl-dihydrobenzofurans

ChemRxiv(2022)10.26434/chemrxiv-2022-2bmrf

N/A

0DataRank · unranked

1 citations

Travis A. Hammerstad, Matthew S. Galliher, Mitchell H. Keylor, Derek A. Pratt, Corey R. J. Stephenson +1 more

Leveraging the Persistent Radical Effect in the Synthesis of trans ‐2,3‐Diaryl Dihydrobenzofurans**

Angewandte Chemie International Edition(2023)10.1002/anie.202305801

N/A

0DataRank · unranked

8 citations

Travis A. Hammerstad, Matthew S. Galliher, Mitchell H. Keylor, Derek A. Pratt, Corey R. J. Stephenson +1 more

Leveraging the persistent radical effect in the synthesis of trans-2,3-diaryl-dihydrobenzofurans

ChemRxiv(2023)10.26434/chemrxiv-2022-2bmrf-v2

N/A

0DataRank · unranked

1 citations

Travis A. Hammerstad, Matthew S. Galliher, Mitchell H. Keylor, Derek A. Pratt, Corey R. J. Stephenson +1 more